3.0.0
767
2025-12-05T09:09:54Z
2025-12-05T09:09:54Z
House
H
HR
2023-02-02
118
https://www.congress.gov/bill/118th-congress/house-bill/767
[Congressional Record Volume 169, Number 22 (Thursday, February 2, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. BUSH:H.R. 767.Congress has the power to enact this legislation pursuantto the following:Section I Article 8The single subject of this legislation is:To codify the current mifepristone Risk Evaluation andMitigation Strategy (REMS) so that people seeking abortioncare can always access medication abortion through telehealthand certified pharmacies, including mail-order pharmacies.[Page H681]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Unknown
2023-02-10T21:41:32Z
    - Referred to
2023-02-10T21:41:32Z
  - Referred To
2023-02-02T14:41:15Z

- Protecting Access to Medication Abortion Act of 2023
118
237
S
2023-02-02
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  - Identical bill
CRS
- 2023-02-10
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-02-02
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-02-02
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-02-02
Introduced in House
IntroReferral
1000
9
Library of Congress
- B001224
Rep. Bush, Cori [D-MO-1]
Cori
Bush
D
MO
1
N
- O000173
Rep. Omar, Ilhan [D-MN-5]
Ilhan
Omar
D
MN
5
2023-02-02
True
- S001200
Rep. Soto, Darren [D-FL-9]
Darren
Soto
D
FL
9
2023-02-02
True
- J000032
Rep. Jackson Lee, Sheila [D-TX-18]
SHEILA
JACKSON LEE
D
TX
18
2023-02-02
True
- M001143
Rep. McCollum, Betty [D-MN-4]
BETTY
MCCOLLUM
D
MN
4
2023-02-02
True
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2023-02-02
True
- B001292
Rep. Beyer, Donald S., Jr. [D-VA-8]
Donald
Beyer
D
VA
S.
8
2023-02-02
True
- C001072
Rep. Carson, Andre [D-IN-7]
André
Carson
D
IN
7
2023-02-02
True
- M001160
Rep. Moore, Gwen [D-WI-4]
Gwen
Moore
D
WI
4
2023-02-07
False
- P000597
Rep. Pingree, Chellie [D-ME-1]
Chellie
Pingree
D
ME
1
2023-02-14
False
- L000582
Rep. Lieu, Ted [D-CA-36]
Ted
Lieu
D
CA
36
2023-02-14
False
- C001131
Rep. Casar, Greg [D-TX-35]
Greg
Casar
D
TX
35
2023-02-27
False
- S001205
Rep. Scanlon, Mary Gay [D-PA-5]
Mary
Scanlon
D
PA
Gay
5
2023-02-28
False
- S001150
Rep. Schiff, Adam B. [D-CA-30]
ADAM
SCHIFF
D
CA
B.
28
2023-03-07
False
- B001318
Rep. Balint, Becca [D-VT-At Large]
Becca
Balint
D
VT
0
2023-03-07
False
- B001223
Rep. Bowman, Jamaal [D-NY-16]
Jamaal
Bowman
D
NY
16
2023-03-07
False
- B001300
Rep. Barragan, Nanette Diaz [D-CA-44]
Nanette
Barragan
D
CA
Diaz
44
2023-03-08
False
- T000487
Rep. Tokuda, Jill N. [D-HI-2]
Jill
Tokuda
D
HI
N.
2
2023-03-21
False
- P000617
Rep. Pressley, Ayanna [D-MA-7]
Ayanna
Pressley
D
MA
7
2023-03-21
False
- R000305
Rep. Ross, Deborah K. [D-NC-2]
Deborah
Ross
D
NC
K.
2
2023-03-30
False
- G000586
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
Jesus
Garcia
D
IL
G.
4
2023-04-10
False
- P000604
Rep. Payne, Donald M., Jr. [D-NJ-10]
Donald
Payne
D
NJ
M.
10
2023-04-10
False
- K000400
Rep. Kamlager-Dove, Sydney [D-CA-37]
Sydney
Kamlager-Dove
D
CA
37
2023-04-17
False
- M001225
Rep. Mullin, Kevin [D-CA-15]
Kevin
Mullin
D
CA
15
2023-04-17
False
- H001081
Rep. Hayes, Jahana [D-CT-5]
Jahana
Hayes
D
CT
5
2023-04-19
False
- P000619
Rep. Peltola, Mary Sattler [D-AK-At Large]
Mary
Peltola
D
AK
Sattler
0
2023-05-09
False
- G000599
Rep. Goldman, Daniel S. [D-NY-10]
Daniel
Goldman
D
NY
S.
10
2023-08-25
False
- C001068
Rep. Cohen, Steve [D-TN-9]
Steve
Cohen
D
TN
9
2023-12-19
False
- L000590
Rep. Lee, Susie [D-NV-3]
Susie
Lee
D
NV
3
2024-04-09
False
- P000616
Rep. Phillips, Dean [D-MN-3]
Dean
Phillips
D
MN
3
2024-05-14
False
- S001226
Rep. Salinas, Andrea [D-OR-6]
Andrea
Salinas
D
OR
6
2024-11-08
False
Health
- Abortion
2023-06-16T19:30:30Z
- Health care coverage and access
2023-06-16T19:30:30Z
- Health technology, devices, supplies
2023-06-16T19:30:30Z
- Prescription drugs
2023-06-16T19:30:30Z
Health
2023-03-06T21:30:24Z
00
2023-02-02
Introduced in House
2023-06-15T13:56:40Z
Protecting Access to Medication Abortion Act of 2023
This bill requires the Food and Drug Administration (FDA) to ensure that patients may receive mifepristone through prescriptions issued via telehealth and filled by mail. The FDA has approved mifepristone for medication abortions (i.e., a procedure in which prescription drugs are used to terminate a pregnancy).
(Mifepristone is subject to a Risk Evaluation and Mitigation Strategy, which imposes various safety-related requirements. During the COVID-19 public health emergency, the FDA suspended enforcement of a requirement that the drug must be dispensed in person, a requirement in the strategy at the time. In January 2023, the FDA updated the strategy to remove the in-person dispensing requirement.)
Under this bill, the FDA must ensure that the strategy for mifepristone (1) does not have an in-person dispensing requirement, (2) allows patients to access prescriptions for mifepristone via telehealth, and (3) authorizes all pharmacies certified to dispense mifepristone to patients to do so via mail.

Protecting Access to Medication Abortion Act of 2023
- Display Title
45

Protecting Access to Medication Abortion Act of 2023
2024-06-11T15:46:17Z
- Short Title(s) as Introduced
101

Protecting Access to Medication Abortion Act of 2023
2024-05-24T13:42:36Z
Introduced in House
IH
- Official Title as Introduced
6

To preserve access to abortion medications.
2024-03-18T20:16:53Z
Introduced in House
IH
- Introduced in House
2023-02-02T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr767ih/xml/BILLS-118hr767ih.xml
2023-02-10
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.